JP4863619B2 - ストレス、不安及び攻撃性を緩和する鳥類宥和フェロモン - Google Patents

ストレス、不安及び攻撃性を緩和する鳥類宥和フェロモン Download PDF

Info

Publication number
JP4863619B2
JP4863619B2 JP2004514864A JP2004514864A JP4863619B2 JP 4863619 B2 JP4863619 B2 JP 4863619B2 JP 2004514864 A JP2004514864 A JP 2004514864A JP 2004514864 A JP2004514864 A JP 2004514864A JP 4863619 B2 JP4863619 B2 JP 4863619B2
Authority
JP
Japan
Prior art keywords
weight
pheromone
avian
chickens
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004514864A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508038A (ja
JP2006508038A5 (https=
Inventor
パジェア，パトリック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fideline
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Publication of JP2006508038A publication Critical patent/JP2006508038A/ja
Publication of JP2006508038A5 publication Critical patent/JP2006508038A5/ja
Application granted granted Critical
Publication of JP4863619B2 publication Critical patent/JP4863619B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
JP2004514864A 2002-06-19 2003-06-19 ストレス、不安及び攻撃性を緩和する鳥類宥和フェロモン Expired - Fee Related JP4863619B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
US60/389,768 2002-06-19
EP02291533.4 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (3)

Publication Number Publication Date
JP2006508038A JP2006508038A (ja) 2006-03-09
JP2006508038A5 JP2006508038A5 (https=) 2006-08-03
JP4863619B2 true JP4863619B2 (ja) 2012-01-25

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514864A Expired - Fee Related JP4863619B2 (ja) 2002-06-19 2003-06-19 ストレス、不安及び攻撃性を緩和する鳥類宥和フェロモン

Country Status (12)

Country Link
EP (1) EP1531839B1 (https=)
JP (1) JP4863619B2 (https=)
CN (1) CN100508968C (https=)
AT (1) ATE468123T1 (https=)
AU (1) AU2003246372B8 (https=)
BR (1) BRPI0311934B1 (https=)
CA (1) CA2490681C (https=)
DK (1) DK1531839T3 (https=)
ES (1) ES2345099T3 (https=)
MX (1) MXPA04013005A (https=)
PT (1) PT1531839E (https=)
WO (1) WO2004000336A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629286B2 (ja) * 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
AU2016221929A1 (en) * 2015-02-20 2017-07-13 Société des Produits Nestlé S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) * 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
EP3727457B1 (fr) 2017-12-22 2025-08-20 Ceva Santé Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH054909A (ja) * 1990-09-28 1993-01-14 Shiseido Co Ltd シヤンプー組成物
JPH11241089A (ja) * 1992-03-24 1999-09-07 Erox Corp ヒトフェロモンを含有する芳香組成物および他の組成物
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP2000509033A (ja) * 1996-04-20 2000-07-18 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 乳酸エステルの使用
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP2001523634A (ja) * 1997-10-01 2001-11-27 キオテック リミテッド フェロモン組成物
JP2002501019A (ja) * 1998-01-21 2002-01-15 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DK1382343T3 (da) * 1998-11-02 2010-04-26 Gilead Sciences Inc Kombinationsterapi til behandling af hepatitis B-virus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH054909A (ja) * 1990-09-28 1993-01-14 Shiseido Co Ltd シヤンプー組成物
JPH11241089A (ja) * 1992-03-24 1999-09-07 Erox Corp ヒトフェロモンを含有する芳香組成物および他の組成物
JP2000509033A (ja) * 1996-04-20 2000-07-18 ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン 乳酸エステルの使用
JP2001523634A (ja) * 1997-10-01 2001-11-27 キオテック リミテッド フェロモン組成物
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
JP2002501019A (ja) * 1998-01-21 2002-01-15 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン

Also Published As

Publication number Publication date
AU2003246372B8 (en) 2009-03-26
DK1531839T3 (da) 2010-09-13
JP2006508038A (ja) 2006-03-09
BR0311934A (pt) 2005-04-05
BRPI0311934B1 (pt) 2015-05-26
CA2490681C (en) 2012-01-24
CN1668318A (zh) 2005-09-14
ATE468123T1 (de) 2010-06-15
CN100508968C (zh) 2009-07-08
EP1531839A1 (en) 2005-05-25
WO2004000336A1 (en) 2003-12-31
EP1531839B1 (en) 2010-05-19
PT1531839E (pt) 2010-07-21
AU2003246372B2 (en) 2008-11-27
MXPA04013005A (es) 2005-09-12
CA2490681A1 (en) 2003-12-31
AU2003246372A1 (en) 2004-01-06
ES2345099T3 (es) 2010-09-15

Similar Documents

Publication Publication Date Title
JP4750232B2 (ja) ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
Youssef et al. Effects of litter quality (moisture, ammonia, uric acid) on development and severity of foot pad dermatitis in growing turkeys
Nicol et al. Farmed bird welfare science review
Brake et al. Effect of age and presence of perches during rearing on tonic immobility fear reactions of broiler breeder pullets
US20240123006A1 (en) Methods of selectively promoting animal welfare through modulation of microbiome
Wakenell Management and medicine of backyard poultry
JP4783569B2 (ja) クモ類を防除するためのアロモン忌避性およびカイロモン誘引性組成物
JP4863619B2 (ja) ストレス、不安及び攻撃性を緩和する鳥類宥和フェロモン
US7723388B2 (en) Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
ERİŞİR The effects of in-ovo injected d-glucose monohydrate and ascorbic acid on hatchability, body weight and early post-hatch performance of geese
JP4754688B2 (ja) ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
Abdulwahid et al. Effect of vitamin e and cod liver oil supplement with bivalent oil based vaccine of newcastle disease and Infectious bronchitis disease on immune response of the broilers
Ezzat et al. EFFECT OF GIBBERELLIC ACID AND ROYAL JELLY INJECTION ON SOME PRODUCTIVE, REPRODUCTIVE AND PHYSIOLOGICAL TRAITS IN MATROUH CHICKENS STRAIN DURING SUMMER SEASON.
Abdel-Fattah et al. Physiological effects of in ovo L carnitine and embryonic thermal conditioning on pre and posthatch development of broiler chicks
Madec et al. Broilers (Gallus gallus) are less stressed if they can smell a mother odorant
Soomro et al. Alternative use of turmeric in induced molting on performance of layers.
HASSAN Atlas of poultry diseases Guidelines for veterinarians
McDonald et al. Review of international literature relevant to stoat control
Ali et al. Leverage of nano-selenium on sexual behavior, reproductive performance, semen characteristics, and prophylactics in rabbit bucks at hot season
Payne Blackhead disease:: a new understanding of an old disease
Kozanoğlu et al. The effect of exogenous melatonin administration on sperm quality and some stress related parameters of broiler breeder males under natural summer conditions.
Cheng Effect of diatomaceous earth on parasite load, egg production, and egg quality of free-range organic laying hens
Ali Behaviour of young dairy bulls under group housing conditions and mature dairy bulls during semen collection
Becerril-Pérez et al. Achievements of research in the field of rabbits
Aboutboul Animal/Lab Studies by Name of Lead Author

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100312

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100414

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100421

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100514

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110218

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110317

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110418

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110816

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110916

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111018

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111108

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141118

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees